The global innovative and generic/biosimilar pharmaceutical industries welcome the entry into force of the Medicrime Convention and encourage countries worldwide to sign and ratify it.
Read more
This blog was originally posted on Business Fights Poverty. After more than two years of intense negotiations, the United Nations’ 193 member states have unanimously agreed on a new Sustainable Development Agenda with 17 goals. Together with the UN Post 2020 Climate targets, these agreements will have far reaching impacts on regulation, markets and expectations...
Read moreThe Sustainable Development Goals (SDGs) mark the start of the widest ever concerted global effort to transform our world by 2030. Reflecting the reality of an integrated world, the SDGs take a holistic and multifaceted approach, interweaving health considerations into all of the goals. The research-based pharmaceutical industry welcomes this approach and confirms its...
Read moreThis blog was originally posted on OECD Insights. As our heads of state prepare to meet later this month in New York at the United Nations General Assembly (UNGA) to adopt the Sustainable Development Goals (SDGs), including the vision of Universal Health Coverage, I will allow myself a moment to appreciate the magnitude of the...
Read moreIn this video, you will hear from pharma’s regulatory affairs professionals, representatives of regulatory authorities, civil society along with other professionals involved in the fight against counterfeit medicines on how best to put together an integrated approach to curb counterfeit medicines. This video is a wrap-up of the “Integrated approach against fake medicines” workshop that...
Read more